167 related articles for article (PubMed ID: 9001725)
1. The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice.
Dluzen DE; Kefalas G
Brain Res; 1996 Nov; 741(1-2):215-9. PubMed ID: 9001725
[TBL] [Abstract][Full Text] [Related]
2. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) reduces norepinephrine concentrations in the olfactory bulbs of male mice.
Dluzen DE
Brain Res; 1992 Jul; 586(1):144-7. PubMed ID: 1511343
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the olfactory bulb and the striatum in mice.
Mitsumoto Y; Mori A; Ohashi S; Nakai M; Moriizumi T
Neurosci Res; 2005 Jan; 51(1):111-5. PubMed ID: 15596247
[TBL] [Abstract][Full Text] [Related]
4. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
Dluzen DE
Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
[TBL] [Abstract][Full Text] [Related]
5. Time-course and dose-response study on the effects of chronic L-DOPA administration on striatal dopamine levels and dopamine transporter following MPTP toxicity.
Fornai F; Battaglia G; Gesi M; Giorgi FS; Orzi F; Nicoletti F; Ruggieri S
Brain Res; 2000 Dec; 887(1):110-7. PubMed ID: 11134595
[TBL] [Abstract][Full Text] [Related]
6. Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice.
Marien M; Briley M; Colpaert F
Eur J Pharmacol; 1993 Jun; 236(3):487-9. PubMed ID: 7689466
[TBL] [Abstract][Full Text] [Related]
7. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to mice on interleukin-1beta and nerve growth factor in the striatum.
Mogi M; Togari A; Ogawa M; Ikeguchi K; Shizuma N; Fan D; Nakano I; Nagatsu T
Neurosci Lett; 1998 Jun; 250(1):25-8. PubMed ID: 9696057
[TBL] [Abstract][Full Text] [Related]
8. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
[TBL] [Abstract][Full Text] [Related]
9. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory/recognition processes in the male mouse.
Dluzen DE; Kreutzberg JD
Brain Res; 1993 Apr; 609(1-2):98-102. PubMed ID: 8099527
[TBL] [Abstract][Full Text] [Related]
10. Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.
Battaglia G; Busceti CL; Cuomo L; Giorgi FS; Orzi F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
Neuropharmacology; 2002 Mar; 42(3):367-73. PubMed ID: 11897115
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic angiotensin-converting enzyme inhibition on striatal dopamine content in the MPTP-treated mouse.
Jenkins TA; Wong JY; Howells DW; Mendelsohn FA; Chai SY
J Neurochem; 1999 Jul; 73(1):214-9. PubMed ID: 10386973
[TBL] [Abstract][Full Text] [Related]
12. Potentiation by reserpine and tetrabenazine of brain catecholamine depletions by MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) in the mouse; evidence for subcellular sequestration as basis for cellular resistance to the toxicant.
Reinhard JF; Daniels AJ; Viveros OH
Neurosci Lett; 1988 Aug; 90(3):349-53. PubMed ID: 3262206
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant responses and lipid peroxidation following intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats: increased susceptibility of olfactory bulb.
Franco J; Prediger RD; Pandolfo P; Takahashi RN; Farina M; Dafre AL
Life Sci; 2007 Apr; 80(20):1906-14. PubMed ID: 17382353
[TBL] [Abstract][Full Text] [Related]
14. The risk is in the air: Intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease.
Prediger RD; Batista LC; Medeiros R; Pandolfo P; Florio JC; Takahashi RN
Exp Neurol; 2006 Dec; 202(2):391-403. PubMed ID: 16908021
[TBL] [Abstract][Full Text] [Related]
15. Influence of intranasal exposure of MPTP in multiple doses on liver functions and transition from non-motor to motor symptoms in a rat PD model.
Datta I; Mekha SR; Kaushal A; Ganapathy K; Razdan R
Naunyn Schmiedebergs Arch Pharmacol; 2020 Feb; 393(2):147-165. PubMed ID: 31468077
[TBL] [Abstract][Full Text] [Related]
16. Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
Andrews AM; Murphy DL
J Neurochem; 1993 Mar; 60(3):1167-70. PubMed ID: 8094744
[TBL] [Abstract][Full Text] [Related]
17. Effect of 4-(4-methoxy-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine , an analog of MPTP, on mouse heart norepinephrine and brain catecholamines.
Hemrick-Luecke SK; Mitch CH; Quimby SJ; Fuller RW
Neurochem Int; 1993 Nov; 23(5):467-70. PubMed ID: 8251928
[TBL] [Abstract][Full Text] [Related]
18. l-dopa-induced reversal in striatal glutamate following partial depletion of nigrostriatal dopamine with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Holmer HK; Keyghobadi M; Moore C; Meshul CK
Neuroscience; 2005; 136(1):333-41. PubMed ID: 16198485
[TBL] [Abstract][Full Text] [Related]
19. [The effect of prolyl-leucyl-glycine (MIF-1) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine levels of the striatum].
Sheng JG
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Aug; 22(4):213-5, 253. PubMed ID: 2575971
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]